loader2
Partner With Us NRI

Astrazeneca Pharma India Ltd share Price Today

Company details

5,335.35
5,520.00
3,125.00
7,220.95
6M Return 17.10%
1Y Return 73.02%
Mkt Cap.(Cr) 13,564.50
Volume 11,479
Div Yield 0.30%
OI
-
OI Chg %
-
Volume 11,479

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Astrazeneca Pharma India Ltd shares SWOT Analysis

Strengths (5)

  • Strong Annual EPS Growth
  • Company with No Debt
  • Book Value per share Improving for last 2 years

Weakness (3)

  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Declining profits every quarter for the past 2 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 5,518.8
R2 5,611.7
R3 5,703.4
Pivot

5,427.05

S1 5,334.1
S2 5,242.4
S3 5,149.5
EMA SMA
5,274.7
5,345.6
5,294.8
4,942.3
5,259.8
5,304.2
5,498.3
4,915.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-09-19 3152.55 74097 BSE
ISHARES MSCI INDIA SMALL-CAP ETF Block Purchase 2022-09-19 3152.55 6542 BSE
ISHARES CORE EMERGING MARKETS MAURITIUS CO Block Sell 2022-09-19 3152.55 74097 BSE
Name Category Shares
AstraZeneca Pharmaceuticals AB PROMOTER 75%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Astrazeneca Pharma India Ltd Stocks COMPARISON

Financials( in Cr) Astrazeneca Pharma India Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Dr Reddys Laboratories Ltd
Price 5,425.80 1,506.55 1,409.15 4,016.35 6,252.10
% Change 1.75 -0.89 0.21 4.49 0.54
Mcap Cr 13,564.50 361,471.81 113,770.12 106,621.64 104,296.28
Revenue TTM Cr 1,002.97 43,885.68 15,790.60 7,767.51 24,669.70
Net Profit TTM Cr 99.29 8,560.84 2,513.47 1,823.38 4,507.30
PE TTM 84.88 38.47 28.78 77.26 19.95
1 Year Return 73.02 54.92 54.91 24.48 29.35
ROCE 30.47 16.79 14.76 19.30 25.99
ROE 22.95 16.46 10.66 14.89 21.21
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 588.69 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 18,183.55 -6,303.96
LAST 3M 84,754.55 29,461.59
LAST 6M 143,739.62 78,027.80
LAST 12M 225,070.18 190,276.46

Astrazeneca Pharma India Ltd Information

Stock PE (TTM)
84.88
Promoter Holding
75%
Book Value
261.986
ROCE
30.47%
ROE
22.95%
Description
  • AstraZeneca Pharmaceuticals Ltd is in the Pharmaceuticals sector is having a market capitalization worth Rs. 7,640.88 crores, it is incorporated in the year 1979. It has reported standalone sales of Rs. 175.40 crores in June 2021. The company is listed on the Bombay Stock Exchange (BSE) with the code 506820, and also listed on the National Stock Exchange (NSE) with the code ASTRAZEN.

    AstraZeneca Pharma deals in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology, and respiratory. It has a workforce of 1400 people across the country. Its manufacturing facility is certified with ISO 14001. AstraZeneca has established a Research & Development facility in Bangalore equipped with a team of 90 employees consisting of scientific experts in the field of regulatory science, clinical science, and patient safety. Its production unit is located in the city of Bengaluru. The company’s plant was the first pharma facility in India to be accredited with Gold Standard Rating under LEED (Leadership in Energy and Environmental Design) certification. The promoters own 75.0% of the stake in the company, Foreign Institutional Investors (FII) own 2.42% of the stake, Domestic Institutional Investors (DII) own 1.02%, and others (such as public & retail investors) hold the balance of 21.56%.

    In June 2021, quarterly net revenue was Rs. 175.4 crores, which has decreased by approximately 9.39 % from Rs. 193.58 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 10.24 crores, which has improved sharply and decreased by nearly 45.03% from a net profit of Rs. 18.63 crores in June 2020. In June 2021, the reported operating profit was at Rs. 141.09 crores, which is decreased by 11.79% as compared to an operating profit of Rs. 159.95 crores for the quarter ending in June 2020. From an EPS of Rs. 18.63 in June 2020, the EPS of AstraZeneca Pharmaceuticals Ltd has reduced and reached an EPS of Rs. 10.24 per share in June 2021. ASTRAZEN's stock closed at Rs. 3,056.35 on 27th August’2021 (NSE). AstraZeneca Pharmaceuticals Ltd has returned 11.06% negatively in the last six months and returned 13.50% negatively in the previous year.

Registered Address

Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road, Bangalore, Karnataka, 560045

Tel : 91-080-67748000
Email : comp.secy:astrazeneca.com
Website : http://www.astrazeneca.in
Registrar

Alpha Systems Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 506820
NSE Code : ASTRAZEN
Book Closure Date (Month) :
BSE Group : A
ISIN : INE203A01020

FAQ’s on Astrazeneca Pharma India Ltd Shares

You can buy Astrazeneca Pharma India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Astrazeneca Pharma India Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 26, 2024 03:55 PM the closing price of Astrazeneca Pharma India Ltd was Rs.5,425.80.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of Apr 26, 2024 03:55 PM, the market cap of Astrazeneca Pharma India Ltd stood at Rs. 13,564.50.

The latest PE ratio of Astrazeneca Pharma India Ltd as of Apr 26, 2024 03:55 PM is 84.88

The latest PB ratio of Astrazeneca Pharma India Ltd as of Apr 26, 2024 03:55 PM is 0.05

The 52-week high of Astrazeneca Pharma India Ltd share price is Rs. 7,220.95 while the 52-week low is Rs. 3,125.00

Download Our

Download App
market app